Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: Results of a randomized phase III trial Article

Meyers, CA, Smith, JA, Bezjak, A et al. (2004). Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: Results of a randomized phase III trial . JOURNAL OF CLINICAL ONCOLOGY, 22(1), 157-165. 10.1200/JCO.2004.05.128

Open Access Industry Collaboration International Collaboration

cited authors

  • Meyers, CA; Smith, JA; Bezjak, A; Mehta, MP; Liebmann, J; Illidge, T; Kunkler, I; Caudrelier, JM; Eisenberg, PD; Meerwaldt, J; Siemers, R; Carrie, C; Gaspar, LE; Curran, W; Phan, SC; Miller, RA; Renschler, MF

sustainable development goals

authors

publication date

  • January 1, 2004

webpage

published in

keywords

  • CELL LUNG-CANCER
  • CEREBRAL METASTASES
  • CLINICAL-TRIAL
  • Life Sciences & Biomedicine
  • MANAGEMENT
  • Oncology
  • PALLIATION
  • PARTITIONING ANALYSIS RPA
  • PROGNOSTIC-FACTORS
  • SURVIVAL
  • Science & Technology
  • TEXAPHYRIN
  • THERAPY-ONCOLOGY-GROUP

Location

  • SAN DIEGO, CALIFORNIA

Digital Object Identifier (DOI)

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 157

end page

  • 165

volume

  • 22

issue

  • 1